- Academic Editor
-
-
-
Announcements
Open Access
Review
Research Advances in Targeted Therapy for Heart Failure
Liu Miao1, Yan-Li Liu1,*
Show Less
1
Department of Cardiology, Liuzhou People's Hospital, Affiliated of Guangxi Medical University, 545006 Liuzhou, Guangxi, China
*Correspondence: gxlyl@126.com (Yan-Li Liu)
Rev. Cardiovasc. Med. 2023, 24(10), 276;
https://doi.org/10.31083/j.rcm2410276
Submitted: 21 February 2023 | Revised: 16 April 2023 | Accepted: 17 May 2023 | Published: 7 October 2023
(This article belongs to the Special Issue Congestive Heart Failure)
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
Cardiovascular disease is one of the major diseases threatening the health of Chinese residents, and the death rate has long been the highest on the disease spectrum in China. With the progress of population aging, the prevalence and mortality of cardiovascular diseases remain on the rise, and the current treatment effect on and prognosis of heart failure (HF) are not satisfactory. It is particularly important to explore the potential pathogenic mechanisms of HF and identify new therapeutic targets.
Keywords
HF
targeted therapy
intestinal flora
signaling channels
mitochondrial autophagy
gene therapy
Funding
2020GXNSFAA297003/National Natural Science Foundation of Guangxi
82060072/National Natural Science Foundation of China
81760073/National Natural Science Foundation of China
2020NBAB0818/Project of Liuzhou Science and Technology
2021CBC0106/Project of Liuzhou Science and Technology
2021CBC0108/Project of Liuzhou Science and Technology
LYRGCC202107/project of Liuzhou people’s Hospital
LYRGCC202203/project of Liuzhou people’s Hospital
Guangxi Medical and health key discipline construction project
Guangxi Health Commission Key Laboratory of Clinical Biotechnology (Liuzhou People’s Hospital)
Figures
Fig. 1.